TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 2, 2012, Pages 167-170

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Histopathology; Immunohistochemistry; Precursor T cell neoplasm; TdT

Indexed keywords

CD34 ANTIGEN; CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; DNA NUCLEOTIDYLEXOTRANSFERASE; LEUKOCYTE ANTIGEN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; FATALITY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD34; CELL ADHESION MOLECULES; DNA NUCLEOTIDYLEXOTRANSFERASE; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-KIT; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 84858314103     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Brunning RD, Flandrin G, Borowitz M, Swerdlow SH, Matutes E, Bennett JM, Head D. Precursor T lymphoblastic leukemia/lymphoblastivc lymphoma. In: In Jaffe ES, Harris NL, Stein H, Vardiman JW eds. World Health Organization Classification of Tumours. Pathology and genetics of haematopoietic and lymphoid tissues. IARC Press. Lyon. 2001. pp115-117.
2. Suzumiya J, Ohshima K, Kikuchi M, Takeshita M, Akamatsu M, Tashiro K. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol 1997; 182: 86-91.
3. Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med 2005; 206: 271-275.
4. Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 2002; 52: 740-746.
5. Brunning RD, Bennett J, Matutes E, Head D, Flandrin G, Harris NL, Vardiman J. Acute myeloid leukemia not otherwise categorized. In Jaffe ES, Harris NL, Stein H, Vardiman JW eds. World Health Organization Classification of Tumours. Pathology and genetics of haematopoietic and lymphoid tissues. IARC Press. Lyon. 2001. pp91-105.
6. Soslow RA, Bhargava V, Warmke RA. MIC-2, TdT, bcl-2, CD34 expression in paraffinembedded high-grade lymphoma/acute lymphoblastic leukemia distinguish between distinct clinicopathologic entities. Hum Pathol 1997; 28: 1158-1165.
7. Uckan D, Hicsonmez G, Yetgin S, Gurgey A, Cetin MK, Okur H, Tuncer AM. CD34/CD117 coexpression in childhood acute leukemia. Leuk Res 2000; 24: 201-206.
8. Pui CH, Mancock MT, Head DR, Rivera GK, Look AT, Saudlund JT, Behm FG. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 1993; 82: 889-894.
9. Robertson PB, Neiman RS, Worapongpaiboon S, John K, Orazi A. 013 (CD99) positivity in hematologic proliferation correlates with TdT positivity. Mod Pathol 1997; 10: 277-282.
10. Muroi K, Nakamura M, Amemiya Y, Suda K, Miura Y. Expression of c-kit (CD117) and CD34 in leukemic cells. Leuk Lymphoma 1995; 16: 297-305.
11. Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumor. Pathol Int 2006; 56: 1-9.
12. Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diang Pathol 2006; 23: 91-102.